
0.72 Delayed Data As of May 27 | ![]() Today’s Change | 0.70 Today|||52-Week Range 15.60 | -84.87% Year-to-Date |
SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $66.0M |
Curis, Inc. 128 Spring Street Lexington Massachusetts 02421 |
James E. Dentzer | President, Chief Executive Officer & Director |
William E. Steinkrauss | Chief Financial & Administrative Officer |
Mark W. Noel | VP-Technology Management & Intellectual Property |
Robert E. Martell | Head-Research & Development |
Reinhard von Roemeling | Senior Vice President-Clinical Development |